SOMPO Japan and M&A Capital Partners Collaborate to Support Business Succession for Medical Institutions – Nikkei

News Highlights

SOMPO Japan Insurance Inc. (SOMPO Japan) and M&A Capital Partners Co., Ltd. have entered into a business alliance to support business succession for medical institutions. Taking into account the unique schemes specific to medical institutions (such as transfer of equity interests, changes in corporate members, and refund of funds), they will provide enterprise valuation services that comprehensively assess medical profits, fixed assets, licenses, staff, and patient base, along with support that accompanies them until stable operation after succession. Through this, they aim to solve challenges such as the aging of management and lack of successors.

M&A Medical Editorial Department’s Perspective

The partnership between SOMPO Japan and M&A Capital Partners not only signifies the entry of new players into the medical institution business succession market but also enhances the depth of their support system. In particular, their explicit commitment to addressing the complex schemes unique to medical institutions and providing “post-succession follow-up” beyond mere M&A completion is significant. For example, the fund refund scheme for medical corporations is essential for inheritance tax planning and smooth asset transfer to successors, but its execution requires advanced specialized knowledge. By collaborating, the two companies are expected to offer more comprehensive solutions by combining their expertise in finance and insurance with their track record in M&A brokerage for these highly specialized challenges. This will be a step towards alleviating the anxiety many medical institution managers, regardless of size, have about “who should I consult?”

Key Discussion Points from This News

• The concretization of business succession support for medical institutions through the collaboration between SOMPO Japan and M&A Capital Partners, entities from different industries and specialized fields.
• The establishment of a detailed support system for schemes unique to medical corporations (transfer of equity interests, changes in corporate members, refund of funds, etc.).
• The establishment of enterprise valuation methods that comprehensively assess the intangible and tangible assets of medical institutions, including medical profits, licenses, and patient base.
• Improvement in success rates for M&A transactions and post-succession success by providing long-term, accompanying support that considers stable operation after M&A completion.

Practical Questions Arising from This News

• How will SOMPO Japan’s insurance products and network specifically integrate with M&A Capital Partners’ support?
• In cases of succession involving a fund refund scheme, to what extent will tax-related advice be provided?
• Will this partnership make it easier for smaller clinics, which have previously hesitated to pursue M&A, to consult more readily?

If You Feel “Should I Consult Too?”

Managers who have vague concerns such as “I’m thinking of retiring soon but have no successor,” “I want to know the current value of my medical institution,” or “M&A procedures are complex and worrying,” may consider consulting with experts, using this partnership as an opportunity. SOMPO Japan’s extensive network and M&A Capital Partners’ expertise may offer a concrete path to solving the unique challenges of medical institutions. Let’s start by organizing your current situation and gathering information.

M&A Medical (Central Medience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here